ACIP Meeting Report – Jan 5th 2022

Following the FDA update on the Emergency Use Authorization (EUA) Fact Sheet for Pfizer-BioNTech COVID-19 vaccine on January 3rd 2022, Advisory Committee on Immunization Practices (ACIP) met to review safety data on this vaccine in children
and adolescents for the purpose of voting on a recommendation to extend use of the booster dose to 12-15yo adolescents.

To view the CDC ACIP Meeting Report from January 5th 2022, see below.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

More SAFETY TEMPLATES

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine

June 1, 2023

Brighton Collaboration Safety Template Peer Review Form – Auro Nipah Vaccine

June 8, 2021

Inactivated Viral Vaccines: Standardized Template For Collection Of Key Information For Benefit-Risk Assessment

August 18, 2020

Protein Vaccines: Standardized Template For Collection Of Key Information For Benefit-Risk Assessment

June 11, 2020

Nucleic Acid (RNA And DNA) Vaccines: Standardized Template For Collection Of Key Information For Benefit-Risk Assessment

June 11, 2020
View All

More Posts

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

© Brighton Collaboration  2023. All rights reserved.